Venous Thromboembolism Chemical Prophylaxis in Patients Undergoing Shoulder Arthroscopy.
Jacob S BudinTolulope RamosKalli SegelMia V RumpsMary K MulcaheyPublished in: JBJS reviews (2024)
» Venous thromboembolism (VTE) after shoulder arthroscopy is rare (0.01%-0.38%) but impacts a significant number of patients because of the high procedure volume.» Studies found no significant benefit in reducing VTE risk with aspirin or low-molecular-weight heparins.» Current guidelines for thromboprophylaxis in shoulder arthroscopy lack consensus and need patient-specific considerations.» Further research is required to develop evidence-based thromboprophylaxis guidelines for shoulder arthroscopy.
Keyphrases
- venous thromboembolism
- direct oral anticoagulants
- rotator cuff
- patients undergoing
- clinical practice
- end stage renal disease
- ejection fraction
- newly diagnosed
- low dose
- chronic kidney disease
- prognostic factors
- type diabetes
- minimally invasive
- cardiovascular disease
- acute coronary syndrome
- coronary artery disease
- atrial fibrillation